STRS Ohio’s X4 Pharmaceuticals XFOR Stock Holding History

STRS Ohio’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-103	Closed	-$31K	–	2266
2020 Q1	$31K	Hold	103	–	–	﹤0.01%	1851
2019 Q4	$33K	Hold	103	–	–	﹤0.01%	1945
2019 Q3	$39K	Buy	103 +40	+63%	+$15.8K	﹤0.01%	1913
2019 Q2	$28K	Buy	63 +56	+800%	+$28.5K	﹤0.01%	1999
2019 Q1	$3K	Hold	7	–	–	﹤0.01%	2036
2018 Q4	$3K	Hold	7	–	–	﹤0.01%	2057
2018 Q3	$2K	Hold	7	–	–	﹤0.01%	2097
2018 Q2	$4K	Hold	7	–	–	﹤0.01%	2102
2018 Q1	$29K	Buy	+7	New	+$20.4K	﹤0.01%	1797

Other funds holding XFOR

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's XFOR Position: Q2 2020 in Review

STRS Ohio sold out of X4 Pharmaceuticals (XFOR) in Q2 2020, closing a stake of 103 shares — an estimated $31K sold.

STRS Ohio first reported a position in XFOR in Q1 2018 and held it in 9 quarters. The position peaked at $39K in Q3 2019. 57 funds tracked by Wall St. Rank hold XFOR as of Q2 2020.

STRS Ohio reported no remaining X4 Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
STRS Ohio sold 103 X4 Pharmaceuticals shares in Q2 2020, an estimated $31K.
STRS Ohio first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 9 quarters.
STRS Ohio's X4 Pharmaceuticals position peaked at $39K in Q3 2019.
57 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2020.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.